The impact of metabolic syndrome components on urinary parameters and risk of stone formation

Author(s):  
Jacob N. Bamberger ◽  
Daniel C. Rosen ◽  
Johnathan A. Khusid ◽  
Elie Kaplan-Marans ◽  
Blair Gallante ◽  
...  
2012 ◽  
Vol 10 (3) ◽  
pp. 195-201
Author(s):  
Cassio José de Oliveira Rodrigues ◽  
Hercules Ferreira Ribeiro ◽  
Artur Beltrame Ribeiro ◽  
Maria Teresa Zanella ◽  
Marcelo Costa Batista

2020 ◽  
Vol 158 (6) ◽  
pp. S-1274
Author(s):  
He Qiu ◽  
Michelle Shi ◽  
Diana Wee ◽  
Sohum A. Patwa ◽  
Tai-Ping Lee

2019 ◽  
Vol 123 (1) ◽  
pp. 1-22 ◽  
Author(s):  
‘Mo’ez Al-Islam’ E. Faris ◽  
Haitham A. Jahrami ◽  
Joud Alsibai ◽  
Asma A. Obaideen

AbstractStudies on the impact of Ramadan diurnal intermittent fasting (RDIF) on the metabolic syndrome (MetS) components among healthy Muslims observing Ramadan month have yielded contradictory results. This comprehensive meta-analysis aimed to obtain a more stable estimate of the effect size of fasting during Ramadan on the MetS components, examine variability among studies, assess the generalisability of reported results and perform subgroup analyses for associated factors. We searched the CINAHL, Cochrane, EBSCOhost, Google Scholar, ProQuest Medical, PubMed/MEDLINE, ScienceDirect, Scopus and Web of Science databases for relevant studies published from 1950 to March 2019. The MetS components analysed were: waist circumference (WC), systolic blood pressure (SBP), fasting plasma/serum glucose (FG), TAG, and HDL-cholesterol. We identified eighty-five studies (4326 participants in total) that were conducted in twenty-three countries between 1982 and 2019. RDIF-induced effect sizes for the MetS components were: small reductions in WC (no. of studies K = 24, N 1557, Hedges’ g = −0·312, 95 % CI −0·387, −0·236), SBP (K = 22, N 1172, Hedges’ g = −0·239, 95 % CI −0·372, −0·106), FG (K = 51, N 2318, Hedges’ g = −0·101, 95 % CI −0·260, 0·004) and TAG (K = 63, N 2862, Hedges’ g = −0·088, 95 % CI −0·171, −0·004) and a small increase in HDL-cholesterol (K = 57, N 2771, Hedges’ g = 0·150, 95 % CI 0·064, 0·236). We concluded that among healthy people, RDIF shows small improvement in the five MetS components: WC, SBP, TAG, FG and HDL.


2020 ◽  
Author(s):  
Afsaneh Aein ◽  
Negar Omidi ◽  
Farnaz Khatami ◽  
Shahed Samat ◽  
Mohammad Rafie Khorgami

Abstract Background This study was to develop, implement, and evaluate the impact of lifestyle education package in order to control metabolic syndrome components.Methods Totally, 72 women and men aged 18-68 years with MetS from two health centers enrolled through randomized sampling to either intervention group who take usual care plus a 3-month lifestyle modification intervention or control group. Anthropometric indices, blood pressure, lipid profiles, and fasting blood glucose were assessed at baseline and after 3month.Results Lifestyle modification program was associated with modest weight loss (2 ± 0.4 kg, P<0.001), a significant reduction in waist circumference (2.3 ± 0.9 cm, P <0.001) and hip circumference (1 ± 0.3cm, P <0.001), and a significant reduction in diastolic blood pressure (5.3 ± 1.4 mm Hg, P<0.001) compared with baseline values in the intervention group. Also, 33.8% of the changes in metabolic syndrome components were attributable to educational intervention (P<0.001, F= 5.27).Conclusions Lifestyle educational package had a significant effect on waist, hip circumference, and diastolic blood pressure at a 3-month. It is suggested that long-term educational interventions should perform to control other MetS components such as blood sugar and systolic blood pressure.Retrospectively registered: This study was retrospectively registered in the Iranian website (www.irct.ir) for registration of clinical trials (IRCT20200212046470N1), on 2020-02-23.


Maturitas ◽  
2013 ◽  
Vol 74 (4) ◽  
pp. 369-374 ◽  
Author(s):  
Charumathi Sabanayagam ◽  
Boon Wee Teo ◽  
E. Shyong Tai ◽  
Tazeen H. Jafar ◽  
Tien Y. Wong

2017 ◽  
Vol 54 (2) ◽  
pp. 139-144 ◽  
Author(s):  
Vilma Maria JUNGES ◽  
Jarbas Marinho CAVALHEIRO ◽  
Eliana Franzoi FAM ◽  
Vera Elizabeth CLOSS ◽  
João Feliz MORAES ◽  
...  

ABSTRACT BACKGROUND The prevalence of obesity and metabolic syndrome is increasing worldwide and both behavior modification and drug therapy have low adherence. Gastric bypass has shown effective results in both reducing weight and improving comorbidities. OBJECTIVE To evaluate the impact of Roux-en-Y Gastric Bypass Surgery (RYGB) on both metabolic syndrome components and the use of associated drugs in obese patients. METHODS Historical cohort of patients subjected to Roux-en-Y Gastric Bypass Surgery (RYGB) between January 2007 and March 2014 in a private clinic. The sample consisted of 273 obese class II and III individuals, 86.4% of whom were female, with age ≥20 years, followed up for 2 months after surgery. Sociodemographic, anthropometric, biochemical, clinical, and drug-use data were collected from patients’ medical records. RESULTS Significant differences were found in weight, body mass index and waist circumference, after 60 postoperative days. Components for metabolic syndrome diagnosis (hypertension P=0.001; hyperglycemia P<0.001; hypertriglyceridemia P=0.006) were reduced after 60 days of postoperative, with the exception HDL-c (P=0.083). There was a significant reduction in the use of antihypertensive (P<0.001), hypoglycemic (P=0.013), lipid lowering (P<0.001), and antiobesity (P=0.010) drugs and increased use of gastroprotective drugs, vitamins, and minerals (P<0.001) after 60 postoperative days. CONCLUSION Patients subjected to Roux-en-Y Gastric Bypass Surgery exhibited both weight loss and significant improvement not only in metabolic syndrome components (except for HDL-c) but in the use of drugs associated with obesity and metabolic syndrome.


2010 ◽  
Vol 74 (1) ◽  
pp. 162-163 ◽  
Author(s):  
Betty Korljan ◽  
Jugoslav Bagatin ◽  
Slaven Kokić ◽  
Nina Berović Matulić ◽  
Sanja Baršić Ostojić ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document